Where does Apollo Endosurgery, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Apollo Endosurgery, Inc. ranks #7,233 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Apollo Endosurgery, Inc. hold?

Apollo Endosurgery, Inc. holds 45 US utility patents granted between 2015 and 2022, spanning 13 technology areas.

What is Apollo Endosurgery, Inc.'s Innovation Score?

Apollo Endosurgery, Inc. has an Innovation Score of 41.9 out of 100 (top 32% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Apollo Endosurgery, Inc.'s patent grant rate increasing or decreasing?

Apollo Endosurgery, Inc.'s recent grant velocity is -98% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Apollo Endosurgery, Inc.'s patents?

Apollo Endosurgery, Inc.'s patents average 15.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Apollo Endosurgery, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Apollo Endosurgery, Inc.

Q: What technology areas does Apollo Endosurgery, Inc. focus on?

Apollo Endosurgery, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 39 patents, ranking #163 of 3,082 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 45 granted patents across 13 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Apollo ranks #7,233 of 49,997 tracked US assignees by granted-patent volume, with 45 patents across 13 technology areas.

#7,233
of 49,997 US assignees by volume: Top 32%
by Innovation Score (41.9/100): 15.4
avg claims per patent: -98%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7233 · US Corporation #7,233 · 45 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 45 grants
UPPER-Q #7,233/49,997
PHOTO-FINISH Adimab
CPC-FOCUS A61F · 13 areas
INNOV-PAR 41.9/100
CLAIMS-RICH 15.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -98% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Adimab, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Apollo’s 41.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.2 pts (32%) Velocity 6.7 pts (16%) Breadth 12.7 pts (30%) Claim depth 9.3 pts (22%)

Qualcomm Incorporated · highest

85
Apollo Endosurgery · this assignee

42
Micware · near

42
Ultragenyx Pharmaceu… · near

42
Zhejiang Hisun… · near

42
Elite Material · near

42
3D Lighting… · lowest

7

What this shows Apollo's Innovation Score is 41.9/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Apollo?

Each dot is one of Apollo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Apollo’s own 15.4 claims/patent is at or below the 15.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Apollo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Apollo's grants concentrate

Apollo Endosurgery, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 86.7% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2015 (30 grants) versus a trough of 1 in 2022. By volume, Apollo sits between Altek Semiconductor Corporation and BVW Holding AG.

Apollo's three-year grant acceleration

Apollo Endosurgery, Inc. shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Altek Semiconduct…

45
APR Beauty Group

45
Aquastar Pool Pro…

45
Adimab

45
Atlas Global

45
Aurora Flight Sci…

45
Avegant

45
BVW Holding

45
Apollo Endosurgery ◀

45

What this shows Apollo holds 45 patents at rank #7,235, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Apollo

By rank, the assignees closest to #7,235 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Apollo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Apollo, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Apollo ranks #163 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Zhejiang Hisun Pharmaceutical Co., Ltd. 42 Micware Co., Ltd. 42 Ultragenyx Pharmaceutical Inc. 42 Elite Material Co., Ltd. 42

Apollo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Apollo Endosurgery, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	30	66.7%
2016	11	24.4%
2017	3	6.7%
2022	1	2.2%

Which technologies does Apollo Endosurgery, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 39

A61B - DIAGNOSIS; SURGERY; Identification 18

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 13

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

Y10T - Technical Subjects Covered BY Former US Classification 2

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 1

G02B - Optical Elements, Systems OR Apparatus 1

F16M - Frames, Casings OR Beds OF Engines, Machines OR Apparatus, NOT Specific TO Engines, Machines OR Apparatus Provided FOR ELSEWHERE; STANDS; Supports 1

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 1

H04B - Transmission 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Apollo Endosurgery, Inc.'s patent record in context - here's where to go next.

Apollo Endosurgery, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 86.7% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #7,233 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Apollo Endosurgery, Inc. against Altek Semiconductor Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.